An Immunohistochemical Analysis of Canine Haemangioma and Haemangiosarcoma

Journal of Comparative Pathology

Volumn 140, Issue 2-3, 2009, Pages 158-168

  Sabattini, S ^a   Bettini, G ^a  

^a Faculty of Veterinary Medicine   (Italy)

Author keywords

dog; haemangioma; haemangiosarcoma; immunohistochemistry; mast cells

Indexed keywords

ANTISERUM; HERMES ANTIGEN; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR; TOLONIUM CHLORIDE; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3; VIMENTIN; VON WILLEBRAND FACTOR;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG DISEASE; FEMALE; GRANULATION TISSUE; HEMANGIOMA; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANIMALS; DOG DISEASES; DOGS; HEMANGIOMA; HEMANGIOSARCOMA; IMMUNOHISTOCHEMISTRY; MAST CELLS; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 60649115621     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2008.10.006     Document Type: Article

References (42)

1. Bettini G., Mandrioli L., Brunetti B., and Marcato P.S. Canine splenic pathology: a retrospective study of 109 surgical samples, with special emphasis on fibrohistiocytic nodules. European Journal of Veterinary Pathology 7 (2001) 101-109
2. von Beust B.R., Suter M.M., and Summers B.A. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Veterinary Pathology 25 (1988) 251-255
3. Brown N.O., Patnaik A.K., and MacEwen E.G. Canine hemangiosarcoma: retrospective analysis of 104 cases. Journal of the American Veterinary Medical Association 186 (1985) 56-58
4. Budd G.T. Management of angiosarcoma. Current Oncology Report 4 (2002) 515-519
5. Clifford C.A., Mackin A.J., and Henry C.J. Treatment of canine hemangiosarcoma: 2000 and beyond. Journal of Veterinary Internal Medicine 14 (2000) 479-485
6. Ferrer L., Fondevila D., Rabanal R.M., and Vilafranca M. Immunohistochemical assessment of CD31 antigen in normal and neoplastic canine endothelial cells. Journal of Comparative Pathology 112 (1995) 319-326
7. Fosmire S.P., Dickerson E.B., Scott A.M., Bianco S.R., Pettengill M.J., Meylemans H., Padilla M., Frazer-Abel A.A., Akhtar N., Getzy D.M., et al. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Laboratory Investigation 84 (2004) 562-572
8. Goldschmidt M.H., and Hendrick M.J. Tumors of the skin and soft tissues. In: Meuten D.J. (Ed). Tumors in Domestic Animals. 4th Edit. (2002), Iowa State Press, Ames 99-101
9. Hammer A.S., Couto C.G., Filppi J., Jetzy D., and Shank K. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine 5 (1991) 160-166
10. Hargis A.M., Ihrke P.J., Spangler W.L., and Stannard A.A. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Veterinary Pathology 29 (1992) 316-328
11. Heller D.A., Clifford C.A., Goldschmidt M.H., Holt D.E., Manfredi M.J., and Sorenmo K.U. Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor. Veterinary Pathology 42 (2005) 350-353
12. Hidalgo A., Robledo M.M., and Teixido J. CD44-mediated hematopoietic progenitor cell adhesion and its complex role in myelopoiesis. Journal of Hematotherapy and Stem Cell Research 11 (2002) 539-547
13. Hidalgo A., Piña P., Guerrero G., Lazos M., and Salcedo M. A simple method for the construction of small format tissue arrays. Journal of Clinical Pathology 56 (2003) 144-146
14. Hoover M.L., Vetvicka V., Hoffpauir J.M., and Tamburro C.H. Human endothelial cell line from an angiosarcoma. In Vitro Cellular & Developmental Biology 29A 3 Pt 1 (1993) 199-202
15. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., and Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. Journal of Cell Biology 153 (2001) 893-904
16. Krump-Konvalinkova V., Kleideiter E., Friedrich U., Klotz U., and Kirkpatrick C.J. Tumorigenic conversion of endothelial cells. Experimental and Molecular Pathology 75 (2003) 154-159
17. Laakkonen P., Waltari M., Holopainen T., Takahashi T., Pytowski B., Steiner P., Hicklin D., Persaud K., Tonra J.R., Witte L., and Alitalo K. Vascular endothelial growth factor receptor 3 (VEGFR-3) is involved in tumor angiogenesis and growth. Cancer Research 67 (2007) 593-599
18. Lamerato-Kozicki A.R., Helm K.M., Jubala C.M., Cutter G.C., and Modiano J.F. Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Experimental Hematology 34 (2006) 870-878
19. Lymboussaki A., Olofsson B., Eriksson U., and Alitalo K. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Journal of Circulation Research 85 (1999) 992-999
20. Marks R.M., Roche W.R., and Czerniecki M. Mast cell granules cause proliferation of human microvascular endothelial cells. Laboratory Investigation 55 (1986) 289-294
21. Masuzawa M., Fujimura T., Hamada Y., Fujita Y., Hara H., Nishiyama S., Katsuoka K., Tamauchi H., and Sakurai Y. Establishment of a human hemangiosarcoma cell line (ISOHAS). International Journal of Cancer 81 (1999) 305-308
22. Meininger C.J., Brightamn S.E., Kelly K.A., and Zetter B.R. Increased stem cell factor release by hemangioma-derived endothelial cells. Laboratory Investigation 72 (1995) 166-173
23. Miettinen M., Sarlomo-Rikala M., and Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of c-kit. Modern Pathology 13 (2000) 536-541
24. Murakami M., Sakai H., Kodama A., Mori T., Maruo K., Yanai T., and Masegi T. Expression of the anti-apoptotic factors bcl-2 and survivin in canine vascular tumours. Journal of Comparative Pathology 139 (2008) 1-7
25. Naor D., Sionov R.V., and Ish-Shalom D. CD44: structure, function, and association with the malignant process. Advances in Cancer Research 71 (1997) 241-319
26. Neuhauser T.S., Derringer G.A., Thompson L.D., Fanburg-Smith J.C., Miettinen M., Saaristo A., and Abbondanzo S.L. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Modern Pathology 13 (2000) 978-987
27. Nocito A., Kononen J., Kallioniemi O.P., and Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. International Journal of Cancer 94 (2001) 1-5
28. Ogilvie G.K., Powers B.E., Mallinckrodt C.H., and Withrow S.J. Surgery and doxorubicin in dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine 10 (1996) 379-384
29. Oksanen A. Haemangiosarcoma in dogs. Journal of Comparative Pathology 88 (1978) 585-595
30. Partanen T.A., Alitalo K., and Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86 (1999) 2406-2412
31. Pearson G.R., and Head K.W. Malignant haemangioendothelioma (angiosarcoma) in the dog. Journal of Small Animal Practice 17 (1976) 737-745
32. Petrova T.V., Bono P., Holnthoner W., Chesnes J., Pytowski B., Sihto H., Laakkonen P., Heikkilä P., Joensuu H., and Alitalo K. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell 13 (2008) 554-556
33. Prymak C., McKee L.J., Goldschmidt M.H., and Glickman L.T. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases. Journal of the American Veterinary Medical Association 193 (1988) 706-712
34. Schatteman G.C., and Awad O. Hemangioblasts, angioblasts, and adult endothelial cell progenitors. The Anatomical Record. Part A, Discoveries in Molecular, Cellular and Evolutionary Biology 276 (2004) 13-21
35. Sorenmo K., Duda L., Barber L., Cronin K., Sammarco C., Usborne A., Goldschmidt M., and Shofer F. Canine hemangiosarcoma treated with standard chemotherapy and minocycline. Journal of Veterinary Internal Medicine 14 (2000) 395-398
36. Srebernik N., and Appleby E.C. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs. Veterinary Record 129 (1991) 408-409
37. Sun Z.J., Zhao Y.F., and Zhao J.H. Mast cells in hemangioma: a double-edged sword. Medical Hypotheses 68 (2007) 805-807
38. Timaran C.H., Grandas O.H., and Bell J.L. Hepatic angiosarcoma: long-term survival after complete surgical removal. American Surgeon 66 (2000) 1153-1157
39. Ward H., Fox L.E., Calderwood-Mays M.B., Hammers A.S., and Couto C.G. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. Journal of Veterinary Internal Medicine 8 (1994) 345-348
40. Waters D.J., Caywood D.D., Hayden D.W., and Klausner J.S. Metastatic pattern in dogs with splenic hemangiosarcomas: clinical implications. Journal of Small Animal Practice 29 (1988) 805-814
41. Yamamoto T., Umeda T., and Nishioka K. Immunohistological distribution of stem cell factor and KIT receptor in angiosarcoma. Acta Dermato-Venereologica 80 (2000) 443-445
42. Yonemaru K., Sakai H., Murakami M., Yanai T., and Masegi T. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Veterinary Pathology 43 (2006) 971-980